Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 09, 2016 12:10 PM ET


Company Overview of Azelon Pharmaceuticals, Inc.

Company Overview

Azelon Pharmaceuticals, Inc. focuses on the development of formulations for the treatment of osteoporosis. It develops ZT-034, a nasal spray formulation of teriparatide that offers an alternate for patients at high risk of fracture. Azelon Pharmaceuticals, Inc. was formerly known as Zelos Therapeutics, Inc. The company was founded in 2000 and is based in West Conshohocken, Pennsylvania.

200 Barr Harbor Drive

Four Tower Bridge

Suite 400

West Conshohocken, PA 19428

United States

Founded in 2000





Key Executives for Azelon Pharmaceuticals, Inc.

Executive Chairman
Age: 59
Vice President
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
Atlantic Pharmaceuticals, Inc. United States
MedPodium Health Products, Inc. United States
MingSight Pharmaceuticals, Inc. United States
Ospemifene Royalty Sub, LLC United States
TWC Global, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Azelon Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at